1. Protocadherin17 Promoter Methylation is a Potential Predictive Biomarker in Clear Cell Renal Cell Carcinoma
   Ying-Li Lin et al, 2015, Medical Science Monitor CrossRef
2. Ablative Options for Renal Cell Carcinoma
   Hal D. Kominsky et al, 2023, Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma CrossRef
3. Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach
   Shankar Siva et al, 2017, Nature Reviews Urology CrossRef
4. The Role of Radiation Therapy in Renal Cell Carcinoma
   Jonathan Verma et al, 2015, Kidney Cancer CrossRef
5. Adaptive radiosurgery based on two simultaneous dose prescriptions in the management of large renal cell carcinoma brain metastases in critical areas: Towards customization
   Georges Sinclair et al, 2020, Surgical Neurology International CrossRef
6. Potential New Therapeutic Approaches for Renal Cell Carcinoma
   David C. Yang et al, 2020, Seminars in Nephrology CrossRef
7. Renal Cancer is Not Radioresistant: Slowly but Continuing Shrinkage of the Tumor After Stereotactic Body Radiation Therapy
   Satoshi Funayama et al, 2019, Technology in Cancer Research & Treatment CrossRef
8. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
   Rohann J.M. Correa et al, 2019, European Urology Focus CrossRef
9. TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II
   Shankar Siva et al, 2018, BMC Cancer CrossRef
10. Stereotactic Body Radiotherapy
    Gargi Kothari et al, 2017, Alternate Fractionation in Radiotherapy CrossRef
11. Stereotactic body radiotherapy for inoperable patients with renal carcinoma
    Léa Kotzki et al, 2024, The French Journal of Urology CrossRef
12. Effect of Stereotactic Body Radiotherapy on the Growth Kinetics and Enhancement Pattern of Primary Renal Tumors
    Maryellen R. M. Sun et al, 2016, American Journal of Roentgenology CrossRef
13. Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
    Alexander Rühle et al, 2019, Clinical and Translational Radiation Oncology CrossRef
14. Stereotactic Body Radiotherapy for Large Primary Renal Cell Carcinoma
    Orit Kaidar-Person et al, 2017, Clinical Genitourinary Cancer CrossRef
15. Stereotactic Body Radiotherapy for Kidney Cancer: Ready for Prime Time?
    E. Carrasco-Esteban et al, 2023, Clinical Oncology CrossRef
16. Novel Ablative Therapies for Renal Tumors
    Maria del Pilar Laguna Pes et al, 2019, Diagnosis and Surgical Management of Renal Tumors CrossRef
17. Stereotactic body radiation therapy to the kidney for metastatic renal cell carcinoma: A narrative review of an emerging concept
    Claire Hao et al, 2023, Cancer Treatment and Research Communications CrossRef
18. Stereotactic body radiotherapy for primary renal cell carcinoma: a systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS)
    Shankar Siva et al, 2024, The Lancet Oncology CrossRef
19. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Cancer: 24-Month Results of the RSR1 Phase 1 Dose Escalation Study
    Ariane Lapierre et al, 2023, Practical Radiation Oncology CrossRef
20. Cancer-specific mortality in non-metastatic T1a renal cell carcinoma treated with radiotherapy versus partial nephrectomy
    Mario de Angelis et al, 2024, World Journal of Urology CrossRef
21. Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function
    C. Senger et al, 2019, BMC Urology CrossRef
22. Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma
    Scott P. Campbell et al, 2015, Journal of Oncology CrossRef